President Trump may like to use the bully pulpit to call on drug makers to lower their prices, but most Americans don’t believe his tough talk will make much of a difference.
To be specific, 55 percent of Americans say his strategy of publicly calling on drug companies to lower their costs will not be too effective or at all effective, according to a poll by the Kaiser Family Foundation. By comparison, 42 percent say this approach will be very or somewhat effective.
About the Author Reprints
Methinks our venerable scribe could have economized on ink in the title to this post – “Most Americans don’t believe Trump’s tough talk” would have been quite sufficient.
It might even have generated more clicks from the non-pharma crowd while still being …. accurate.